Strikingly, the E-selectin-binding capacity of AML cells was higher after relapse or with treatment resistance, and, notably, high levels of CD45RA positivity were retained at all time points measured (n = 4; Figs. 4D and S5). The gene discussed is SELE; the disease is acute myeloid leukemia.